Keywords: protherics, cuts, loss, over, six, months, uk-headquartered
Protherics cuts loss 23% over six months
Article | 01 December 2008
UK-headquartered biopharmaceuticals firm Protherics achieved higher revenues and lower costs year-on-year for the six months to September 30, 2008, due to favorable ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
